C. Nilsson

448 total citations
9 papers, 366 citations indexed

About

C. Nilsson is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Nilsson has authored 9 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in C. Nilsson's work include Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). C. Nilsson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). C. Nilsson collaborates with scholars based in United States and India. C. Nilsson's co-authors include Elliot Israel, Yuko Fujiwara, N P Gerard, Craig Gérard, Bao Lu, Alison A. Humbles, Craig M. Lilly, Alan F. Wahl, D. Barone and Martha Hayden-Ledbetter and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

C. Nilsson

9 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Nilsson United States	6	222	129	76	73	48	9	366
Hui-Qing Xiao United States	8	258 1.2×	283 2.2×	48 0.6×	114 1.6×	31 0.6×	10	586
Melanie Lukkes Netherlands	12	263 1.2×	178 1.4×	40 0.5×	39 0.5×	6 0.1×	17	425
Nancy Wood United States	9	283 1.3×	168 1.3×	9 0.1×	95 1.3×	39 0.8×	9	455
J.A. van Roon Netherlands	8	160 0.7×	98 0.8×	26 0.3×	21 0.3×	53 1.1×	19	420
Kimiko Kasahara Japan	11	189 0.9×	92 0.7×	13 0.2×	48 0.7×	22 0.5×	29	394
Alexandra Joseph United States	7	162 0.7×	85 0.7×	23 0.3×	13 0.2×	40 0.8×	8	378
J. Elsner Germany	8	119 0.5×	37 0.3×	40 0.5×	44 0.6×	16 0.3×	10	333
Ahsen Morva France	5	251 1.1×	32 0.2×	48 0.6×	14 0.2×	37 0.8×	9	348
Cornelis E. Hack Netherlands	7	148 0.7×	32 0.2×	96 1.3×	26 0.4×	17 0.4×	8	295
Yumi Kurokawa Japan	10	187 0.8×	68 0.5×	31 0.4×	55 0.8×	12 0.3×	16	319

Countries citing papers authored by C. Nilsson

Since Specialization

Citations

This map shows the geographic impact of C. Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Nilsson more than expected).

Fields of papers citing papers by C. Nilsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Nilsson. The network helps show where C. Nilsson may publish in the future.

Co-authorship network of co-authors of C. Nilsson

This figure shows the co-authorship network connecting the top 25 collaborators of C. Nilsson. A scholar is included among the top collaborators of C. Nilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Nilsson. C. Nilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Algate, Paul A., C. Nilsson, Mien Sho, et al.. (2010). TRU-016, An Anti-CD37 SMIP™ Biologic, In Combination with Other Therapeutic Drugs In Models of Non-Hodgkin's Lymphoma. Blood. 116(21). 3931–3931. 6 indexed citations

Baum, Peter, Brian Gordon, C. Nilsson, et al.. (2009). Evaluation of the effect of TRU-016, an anti-CD37 directed SMIP in combination with other therapeutic drugs in models of non-Hodgkin's lymphoma. Journal of Clinical Oncology. 27(15_suppl). 8571–8571. 18 indexed citations

Hayden-Ledbetter, Martha, Erik Espling, William Brady, et al.. (2009). CD20-Directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells. Clinical Cancer Research. 15(8). 2739–2746. 27 indexed citations

Cerveny, Charles G., Laura S. Grosmaire, C. Nilsson, et al.. (2008). In vitro and in vivo anti-B cell lymphoma activities of TRU-016. Journal of Clinical Oncology. 26(15_suppl). 3074–3074. 3 indexed citations

Grosmaire, Laura S., Erik Espling, C. Nilsson, et al.. (2007). Depletion of Normal and Malignant B cells with a CD37-specific SMIP molecule. Journal of Clinical Oncology. 25(18_suppl). 3063–3063. 1 indexed citations

Barone, D., C. Nilsson, J A Ledbetter, Martha Hayden-Ledbetter, & K M Mohler. (2006). Efficacy of SMIP-016, a novel CD37-directed biologic therapy, in human NHL tumor xenograft models. Journal of Clinical Oncology. 24(18_suppl). 2565–2565. 1 indexed citations

Barone, D., C. Nilsson, J A Ledbetter, Martha Hayden-Ledbetter, & K M Mohler. (2005). TRU-015, a novel CD20-directed biologic therapy, demonstrates significant anti-tumor activity in human tumor xenograft models. Journal of Clinical Oncology. 23(16_suppl). 2549–2549. 5 indexed citations

Richardson, Frank C., Chris Black, Katherine Richardson, et al.. (2004). Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors. Cancer Chemotherapy and Pharmacology. 55(3). 213–221. 7 indexed citations

Humbles, Alison A., Bao Lu, C. Nilsson, et al.. (2000). A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature. 406(6799). 998–1001. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact